184 related articles for article (PubMed ID: 16169691)
1. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Mar; 53(4):454-61. PubMed ID: 16169691
[TBL] [Abstract][Full Text] [Related]
2. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
3. Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):277-84. PubMed ID: 16414216
[TBL] [Abstract][Full Text] [Related]
4. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.
Taylor LJ; Jackson TL; Reid JG; Duffy SR
BJOG; 2003 Sep; 110(9):794-8. PubMed ID: 14511960
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
9. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
[TBL] [Abstract][Full Text] [Related]
10. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index.
Belisário MS; Vassallo J; Andrade LA; Alvarenga M; Pinto GA; Monteiro IM
Maturitas; 2006 Jan; 53(1):114-8. PubMed ID: 15894442
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
Gul A; Ugur M; Iskender C; Zulfikaroglu E; Ozaksit G
Arch Gynecol Obstet; 2010 Mar; 281(3):479-83. PubMed ID: 19506890
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor expression in endometria from women treated with tamoxifen.
Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
Duffy SR; Taylor L
Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
[TBL] [Abstract][Full Text] [Related]
15. Abnormal uterine bleeding on hormone replacement: the importance of intrauterine structural abnormalities.
Akkad AA; Habiba MA; Ismail N; Abrams K; al-Azzawi F
Obstet Gynecol; 1995 Sep; 86(3):330-4. PubMed ID: 7651636
[TBL] [Abstract][Full Text] [Related]
16. K-ras mutation in tamoxifen-related endometrial polyps.
Hachisuga T; Miyakawa T; Tsujioka H; Horiuchi S; Emoto M; Kawarabayashi T
Cancer; 2003 Nov; 98(9):1890-7. PubMed ID: 14584071
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors.
Pizer ES; Lax SF; Kuhajda FP; Pasternack GR; Kurman RJ
Cancer; 1998 Aug; 83(3):528-37. PubMed ID: 9690546
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas.
Saegusa M; Okayasu I
J Pathol; 1997 Aug; 182(4):429-36. PubMed ID: 9306964
[TBL] [Abstract][Full Text] [Related]
19. [Endometrial cytology in normal postmenopausal women and during hormone replacement therapy].
Wei Y; Xue J; Lin S
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):432-5. PubMed ID: 9639733
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps.
Erdemoglu E; Güney M; Karahan N; Mungan T
Maturitas; 2008 Mar; 59(3):268-74. PubMed ID: 18378414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
